Abstract
Engagement of CD137 receptor by agonistic monoclonal antibodies (mAb) stimulates IFN-γ production and eradicates established tumors in syngeneic mouse models. Using IFN-γ-deficient mice or neutralizing mAb, we demonstrate that IFN-γ is an absolute requirement for the antitumor effect of CD137 mAb. Despite progressive tumor growth in IFN-γ-depleted mice, a fully competent CD8+ cytolytic T cell (CTL) response developed in the lymph nodes. In addition, tumor cell sensitivity to IFN-γ was not required because expression of a dominant-negative IFN-γ receptor on the tumor did not affect the therapeutic effect of CD137 mAb. However, in the absence of IFN-γ, the number of tumor-infiltrating CD8+ CTLs was drastically decreased. Our results demonstrate that IFN-γ is a critical factor regulating the infiltration of antigen-specific CTL into the tumor.
Original language | English (US) |
---|---|
Pages (from-to) | 4413-4418 |
Number of pages | 6 |
Journal | Cancer research |
Volume | 62 |
Issue number | 15 |
State | Published - Aug 1 2002 |
ASJC Scopus subject areas
- Oncology
- Cancer Research